Stay updated on Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.

Latest updates to the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page
- Check7 days agoChange DetectedThe locations list adds Taoyuan, Taiwan, 333 (replacing Taoyuan District, Taiwan, 333) to represent a new trial site; a 2026 publication citation about KEYNOTE-590 was added to Publications.SummaryDifference0.0%

- Check14 days agoChange DetectedThe page’s revision/version number was updated from v3.5.2 to v3.5.3, indicating a general system/version update rather than a change to the study record content.SummaryDifference0.0%

- Check21 days agoChange DetectedAdded the health-related quality-of-life publication for KEYNOTE-590 (Oncologist, 2024) with its erratum and removed the prior reference version (v3.5.0).SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision: v3.4.3 has been added to the page, replacing Revision: v3.4.2 in the revision history.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page revision updated from v3.4.1 to v3.4.2; this appears to be a version-label change rather than a modification of core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.